Physician profile
Fatima Ali
NPI 1467711689
$1,305.57
in general payments reported to CMS, 2019-2025
19 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2021: $19.34 · 2022: $63.98 · 2023: $60.31 · 2024: $582 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $478.58 | 2023-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa, Photrexa |
| Avedro INC. | $141.63 | 2019 | |
| Boston Scientific Corporation | $77.64 | 2024 | |
| Biotissue Holdings INC. | $68.10 | 2019-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $65.01 | 2019-2023 | Veritas Vision System, Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $51.25 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $51.03 | 2025 | Oxervate |
| New World Medical,INC. | $49.92 | 2022-2025 | Clearpath, Ahmed Glaucoma Valve, Via360 |
| Sight Sciences, INC. | $42.79 | 2024 | Omni Surgical System |
| Alcon Vision LLC | $42.78 | 2024-2025 | Rocklatan, Hydrus Microstent |
| Allergan, INC. | $42.55 | 2021-2022 | |
| Rxsight INC | $41.14 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Alimera Sciences, INC. | $26.20 | 2024 | Yutiq, Iluvien |
| Shire North American Group INC | $24.41 | 2019 | |
| Harrow Eye, LLC | $23.80 | 2024 | Vevye |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $21.95 | 2025 | Lensar Laser System |
| Thea Pharma INC. | $20.57 | 2022 | |
| Bausch & Lomb Americas INC. | $18.57 | 2025 | Envista Envy Iol |
| Eyevance Pharmaceuticals LLC | $17.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fatima Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.